Kazuma Murakami

ResearcherID Researcher Name Resolver ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Ischemia Reperfusion Injury

Silver Nanoparticles

Cognitive Decline

Crystal Structure

Top Venues

RSC chemical biology

ACS chemical neuroscience

The Journal of biological chemistry

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Kota Taniwa, Kazuma Murakami, Yoshiki Sakaguchi, Naotaka Izuo, Mizuho Hanaki, Nobuaki Sampa, Toshiaki Kume, Takahiko Shimizu, Kazuhiro Irie
Detection of Dietary Chalcone and Flavonoid Metabolites in Mice Using UPLC-MS/MS and Their Modulatory Effects on Amyloid β Aggregation. Journal of agricultural and food chemistry (2023)
Kazuma Murakami, Yoshiki Sakaguchi, Kota Taniwa, Naotaka Izuo, Mizuho Hanaki, Taiji Kawase, Kenji Hirose, Takahiko Shimizu, Kazuhiro Irie
Lysine-targeting inhibition of amyloid β oligomerization by a green perilla-derived metastable chalcone in vitro and in vivo . RSC chemical biology 3 (12) (2022)
Kazuma Murakami, Kenjiro Ono
Interactions of amyloid coaggregates with biomolecules and its relevance to neurodegeneration. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 (9) (2022)
Yohei Morishita, Kento Tsukada, Kazuma Murakami, Kazuhiro Irie, Teigo Asai
Synthetic Biology-Based Discovery of Diterpenoid Pyrones from the Genome of Eupenicillium shearii . Journal of natural products 85 (2) (2022)
Kazuma Murakami, Yoshiki Sakaguchi, Kota Taniwa, Naotaka Izuo, Mizuho Hanaki, Taiji Kawase, Kenji Hirose, Takahiko Shimizu, Kazuhiro Irie
Lysine-targeting inhibition of amyloid β oligomerization by a green perilla-derived metastable chalcone in vitro and in vivo . RSC chemical biology 3 (12) (2022)
Kazuma Murakami, Shiori Horii, Mizuho Hanaki, Kazuhiro Irie
Searching for Natural Products That Delay Nucleation Phase and Promote Elongation Phase of Amyloid β42 toward Alzheimer's Disease Therapeutics. ACS chemical neuroscience 12 (18) (2021)
Kento Tsukada, Shono Shinki, Akiho Kaneko, Kazuma Murakami, Kazuhiro Irie, Masatoshi Murai, Hideto Miyoshi, Shingo Dan, Kumi Kawaji, Hironori Hayashi, Eiichi N Kodama, Aki Hori, Emil Salim, Takayuki Kuraishi, Naoya Hirata, Yasunari Kanda, Teigo Asai
Synthetic biology based construction of biological activity-related library of fungal decalin-containing diterpenoid pyrones. Nature communications 11 (1) (2020)
Kazuma Murakami, Yayoi Obata, Asa Sekikawa, Haruka Ueda, Naotaka Izuo, Tatsuya Awano, Keiji Takabe, Takahiko Shimizu, Kazuhiro Irie
An RNA aptamer with potent affinity for a toxic dimer of amyloid β42 has potential utility for histochemical studies of Alzheimer's disease. The Journal of biological chemistry 295 (15) (2020)
Kazuma Murakami, Tomomi Yamaguchi, Naotaka Izuo, Toshiaki Kume, Hideyuki Hara, Kazuhiro Irie
Synthetic and Biophysical Studies on the Toxic Conformer in Amyloid β with the E22Δ Mutation in Alzheimer Pathology. ACS chemical neuroscience 11 (19) (2020)
Kazuma Murakami, Haruka Kato, Mizuho Hanaki, Yoko Monobe, Ken-Ichi Akagi, Taiji Kawase, Kenji Hirose, Kazuhiro Irie
Synthetic and biochemical studies on the effect of persulfidation on disulfide dimer models of amyloid β42 at position 35 in Alzheimer's etiology. RSC advances 10 (33) (2020)
Kazuma Murakami, Kazuhiro Irie
Three Structural Features of Functional Food Components and Herbal Medicine with Amyloid β42 Anti-Aggregation Properties. Molecules (Basel, Switzerland) 24 (11) (2019)